Insiders · ALNY

Pyott David E I

Director at Alnylam Pharmaceuticals, Inc. (ALNY)

Pyott David E I has filed 28 insider reports with the SEC since July 2021, as director at Alnylam Pharmaceuticals, Inc. (ALNY), director at Tarsus Pharmaceuticals, Inc. (TARS) and director at Pliant Therapeutics, Inc. (PLRX) and at 1 more company. In the last 12 months Pyott David E I sold $1.15M of stock on the open market. The latest filing, on November 12, 2026, reports exercise or conversion of a derivative at Alnylam Pharmaceuticals, Inc. (ALNY).

Filings
28
Companies
4
Bought on market
None
Sold on market
$10.5M

Companies where Pyott David E I is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Alnylam Pharmaceuticals, Inc. logo
ALNY
Alnylam Pharmaceuticals, Inc.
Director5,362$10.5M$159.73Nov 12, 2026
Tarsus Pharmaceuticals, Inc. logo
TARS
Tarsus Pharmaceuticals, Inc.
Directorsince February 20261,383$78.68Sep 17, 2026
Pliant Therapeutics, Inc. logo
PLRX
Pliant Therapeutics, Inc.
Director$0.6932Jun 10, 2025
Biomarin Pharmaceutical Inc logo
BMRN
Biomarin Pharmaceutical Inc
Director49,750$57.99May 23, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Pyott David E I with

Other insiders at the same companies

Questions about Pyott David E I

What is Pyott David E I's role at Alnylam Pharmaceuticals, Inc.?
Pyott David E I reports to the SEC as director at Alnylam Pharmaceuticals, Inc. (ALNY), according to the latest filing on November 12, 2026. Pyott David E I has also filed as director at Tarsus Pharmaceuticals, Inc. (TARS), director at Pliant Therapeutics, Inc. (PLRX) and director at Biomarin Pharmaceutical Inc (BMRN).
How many shares does Pyott David E I own?
After the latest filing that states it, Pyott David E I directly owned 5,362 shares of Alnylam Pharmaceuticals, Inc. (ALNY), 1,383 shares of Tarsus Pharmaceuticals, Inc. (TARS) and 49,750 shares of Biomarin Pharmaceutical Inc (BMRN). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Pyott David E I bought or sold stock recently?
The most recent open-market sale was on June 1, 2026: sold 3,830 shares of Alnylam Pharmaceuticals, Inc. (ALNY) for $1.15M at an average of $299.18.
How do I get alerts when Pyott David E I files?
Follow Pyott David E I on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Pyott David E I filed 2 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Pyott David E I (SEC CIK 0001051578). Totals count each trade once, skipping amendments whose original is on file, from Jul 2, 2021 on. View on SEC EDGAR